Study Evaluating REVLIMID A Combination Compared to Autologous Stem Cell Transplant with or without REVLIMID Maintenance in Newly-Diagnosed Multiple Myeloma Presented at ASCO REVLIMID maintenance therapy demonstrated a statistically significant reduction in the risk of disease progression and significant improvement in overall survival regardless ... (more)
http://eon.businesswire.com/news/eon/20130604005955/en/Study-Evaluating-REVLIMID%C2%AE-Combination-Compared-Autologous-Stem
http://eon.businesswire.com/news/eon/20130604005955/en/Study-Evaluating-REVLIMID%C2%AE-Combination-Compared-Autologous-Stem
No comments:
Post a Comment